Tart Cherry Extract, Uric Acid, and the Gout Claim That Needs a Brake

Wed, 09 Sep 2026 00:45:00 +0700

A tart cherry study can sound bigger than it is if you only read the lab numbers.

That’s the trap with the new tart cherry extract trial. A 2026 Journal of Dietary Supplements randomized, double-blind, placebo-controlled crossover study reported lower plasma urate and lower C-reactive protein, or CRP, after four weeks of a standardized tart cherry extract in 10 selected healthy adults (Taylor & Francis; PubMed).

And yes, the urate movement was attention-grabbing. But no, this does not prove tart cherry treats gout. It doesn’t prove fewer flares. It doesn’t prove kidney-stone protection. It doesn’t give anyone a reason to swap out allopurinol, febuxostat, probenecid, pegloticase, colchicine, NSAIDs, steroids, or clinician-guided gout care.

The useful story is narrower - and honestly more useful: lab markers can move in a small supplement study without becoming a treatment claim.

Gout on Alternative Medicine Zone

Tart Cherry Extract, Uric Acid, and the Gout Claim That Needs a Brake